A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/19 (2006.01) A61K 31/192 (2006.01) A61P 11/06 (2006.01)
Patent
CA 2352543
A class of .OMEGA.-substituted(1,4-benzoquinon-2-yl)alkanoic acids are useful in the treatment of chronic obstructive pulmonary disease (COPD). The preferred compound for the method of treatment is 7-(3,5,6-trimethyl-1,4- benzoquinon-2-yl)-7-phenylheptanoic acid or a pharmaceutically acceptable salt, ester or pro-drug thereof.
Cette invention se rapporte à une classe d'acides [1,4-benzoquinon-2-yl]alcanoïques .OMEGA.-substitués, qui servent dans le traitement des bronchopneumopathies chroniques obstructives (BPCO). Le composé préféré pour ce procédé de traitement est l'acide-(3,5,6-triméthyl-1,4-benzoquinon-2-yl)-7-phénylheptanoïque ou un sel, ester ou promédicament de cet acide, acceptables sur le plan pharmaceutique.
Killian Anthony
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Tap Pharmaceutical Products Inc.
LandOfFree
Method of treating chronic obstructive pulmonary disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating chronic obstructive pulmonary disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating chronic obstructive pulmonary disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1498059